StonvexLoading…
StonvexStonvexStonvexCore line items from GNRC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-09-30 |
|---|---|---|---|---|
Revenue | $4.21B | $4.30B | $4.02B | $1.07B |
Operating Income | $289.19M | $536.74M | $386.20M | $104.78M |
Net Income | $159.55M | $316.31M | $214.61M | $60.38M |
EPS (Diluted) | $2.69 | $5.39 | $3.27 | $0.97 |
Total Assets | $5.57B | $5.11B | $5.09B | Not available |
Total Liabilities | $2.93B | $2.61B | $2.74B | Not available |
Cash & Equivalents | $341.41M | $281.28M | $200.99M | Not available |
Free Cash Flow OCF − CapEx | $268.13M | $604.57M | $392.61M | Not available |
Shares Outstanding | 59.28M | 60.35M | 62.06M | Not available |